Μοντελουκάστη (Greek Wikipedia)
Analysis of information sources in references of the Wikipedia article "Μοντελουκάστη" in Greek language version.
refsWebsite
Global rank
Greek rank
1st place
1st place
6th place
5th place
3,912th place
594th place
3,823rd place
2,141st place
5th place
8th place
910th place
1,418th place
archive-it.org
wayback.archive-it.org
- «Updated Information on Leukotriene Inhibitors: Montelukast (marketed as Singulair), Zafirlukast (marketed as Accolate), and Zileuton (marketed as Zyflo and Zyflo CR)». U.S. Food and Drug Administration (FDA). 12 Ιουνίου 2009. Αρχειοθετήθηκε από το πρωτότυπο στις 14 Νοεμβρίου 2017. Ανακτήθηκε στις 1 Μαρτίου 2017.
archive.org
- Grainger, J.; Drake-Lee, A. (2006). «Montelukast in allergic rhinitis: a systematic review and meta-analysis». Clinical Otolaryngology (Wiley) 31 (5): 360–367. doi:. ISSN 0307-7772. PMID 17014443. https://archive.org/details/sim_clinical-otolaryngology_2006-10_31_5/page/360. «regarded as second line therapy. When used, montelukast should be used in combination with an antihistamine.».
- «Hepatotoxicity due to a drug interaction between amodiaquine plus artesunate and efavirenz». Clin. Infect. Dis. 44 (6): 889–91. March 2007. doi:. PMID 17304470. https://archive.org/details/sim_clinical-infectious-diseases_2007-03-15_44_6/page/n170.
clincalc.com
- «The Top 300 of 2020». ClinCalc. Ανακτήθηκε στις 4 Μαρτίου 2020.
- «Montelukast - Drug Usage Statistics». ClinCalc. 23 Δεκεμβρίου 2019. Ανακτήθηκε στις 11 Απριλίου 2020.
doi.org
dx.doi.org
- Grainger, J.; Drake-Lee, A. (2006). «Montelukast in allergic rhinitis: a systematic review and meta-analysis». Clinical Otolaryngology (Wiley) 31 (5): 360–367. doi:. ISSN 0307-7772. PMID 17014443. https://archive.org/details/sim_clinical-otolaryngology_2006-10_31_5/page/360. «regarded as second line therapy. When used, montelukast should be used in combination with an antihistamine.».
- «Mastocytosis: Update on pharmacotherapy and future directions». Expert Opinion on Pharmacotherapy 14 (15): 2033–2045. October 2013. doi:. PMID 24044484.
- «Hepatotoxicity due to a drug interaction between amodiaquine plus artesunate and efavirenz». Clin. Infect. Dis. 44 (6): 889–91. March 2007. doi:. PMID 17304470. https://archive.org/details/sim_clinical-infectious-diseases_2007-03-15_44_6/page/n170.
- «Antileukotriene agents for the treatment of lung disease». Am. J. Respir. Crit. Care Med. 188 (5): 538–544. September 2013. doi:. PMID 23822826.
drugs.com
- «Montelukast (Singulair) Use During Pregnancy». Drugs.com. 13 Δεκεμβρίου 2019. Ανακτήθηκε στις 4 Μαρτίου 2020.
- «Montelukast Sodium Monograph for Professionals». Drugs.com. AHFS. Ανακτήθηκε στις 23 Δεκεμβρίου 2018.
- «Montelukast Sodium». The American Society of Health-System Pharmacists. Ανακτήθηκε στις 3 Απριλίου 2011.
fda.gov
- «Updated Information on Leukotriene Inhibitors: Montelukast (marketed as Singulair), Zafirlukast (marketed as Accolate), and Zileuton (marketed as Zyflo and Zyflo CR)». U.S. Food and Drug Administration (FDA). 12 Ιουνίου 2009. Αρχειοθετήθηκε από το πρωτότυπο στις 14 Νοεμβρίου 2017. Ανακτήθηκε στις 1 Μαρτίου 2017.
- «Singulair (montelukast) and All Generics: Strengthened Boxed Warning». U.S. Food and Drug Administration (FDA). 4 Μαρτίου 2020. Ανακτήθηκε στις 4 Μαρτίου 2020.
Αυτό το λήμμα περιλαμβάνει κείμενο από αυτή την πηγή, που είναι κοινό κτήμα.
gov.uk
- «Montelukast (Singulair): reminder of the risk of neuropsychiatric reactions». Ανακτήθηκε στις 19 Σεπτεμβρίου 2019.
medicines.org.uk
- «Montelukast 10 mg film coated tablets - Summary of Product Characteristics (SmPC) - (eMC)». Αρχειοθετήθηκε από το πρωτότυπο στις 23 Δεκεμβρίου 2018. Ανακτήθηκε στις 23 Δεκεμβρίου 2018.
nih.gov
ncbi.nlm.nih.gov
- Grainger, J.; Drake-Lee, A. (2006). «Montelukast in allergic rhinitis: a systematic review and meta-analysis». Clinical Otolaryngology (Wiley) 31 (5): 360–367. doi:. ISSN 0307-7772. PMID 17014443. https://archive.org/details/sim_clinical-otolaryngology_2006-10_31_5/page/360. «regarded as second line therapy. When used, montelukast should be used in combination with an antihistamine.».
- «Mastocytosis: Update on pharmacotherapy and future directions». Expert Opinion on Pharmacotherapy 14 (15): 2033–2045. October 2013. doi:. PMID 24044484.
- «Hepatotoxicity due to a drug interaction between amodiaquine plus artesunate and efavirenz». Clin. Infect. Dis. 44 (6): 889–91. March 2007. doi:. PMID 17304470. https://archive.org/details/sim_clinical-infectious-diseases_2007-03-15_44_6/page/n170.
- «Antileukotriene agents for the treatment of lung disease». Am. J. Respir. Crit. Care Med. 188 (5): 538–544. September 2013. doi:. PMID 23822826.
pubmedcentral.nih.gov
- «Mastocytosis: Update on pharmacotherapy and future directions». Expert Opinion on Pharmacotherapy 14 (15): 2033–2045. October 2013. doi:. PMID 24044484.
nlm.nih.gov
- Montelukast article on Medline Plus https://www.nlm.nih.gov/medlineplus/druginfo/meds/a600014.html "Montelukast comes as a tablet, a chewable tablet, and granules to take by mouth. Montelukast is usually taken once a day with or without food."
web.archive.org
- «Montelukast 10 mg film coated tablets - Summary of Product Characteristics (SmPC) - (eMC)». Αρχειοθετήθηκε από το πρωτότυπο στις 23 Δεκεμβρίου 2018. Ανακτήθηκε στις 23 Δεκεμβρίου 2018.
- Artesunate Amodiaquine Winthrop (artesunate, amodiaquine) [summary of product characteristics]. Gentilly, France: Sanofi-aventis; August 2010. http://www.wipo.int/export/sites/www/research/en/data/sanofi/marketed_products/Artesunate_and_Amodiquine.pdf Αρχειοθετήθηκε 2016-10-24 στο Wayback Machine.
wipo.int
- Artesunate Amodiaquine Winthrop (artesunate, amodiaquine) [summary of product characteristics]. Gentilly, France: Sanofi-aventis; August 2010. http://www.wipo.int/export/sites/www/research/en/data/sanofi/marketed_products/Artesunate_and_Amodiquine.pdf Αρχειοθετήθηκε 2016-10-24 στο Wayback Machine.
worldcat.org
- Grainger, J.; Drake-Lee, A. (2006). «Montelukast in allergic rhinitis: a systematic review and meta-analysis». Clinical Otolaryngology (Wiley) 31 (5): 360–367. doi:. ISSN 0307-7772. PMID 17014443. https://archive.org/details/sim_clinical-otolaryngology_2006-10_31_5/page/360. «regarded as second line therapy. When used, montelukast should be used in combination with an antihistamine.».